Renhe Pharmaceutical announced that it plans to adjust the investment scale and complete the “Digital Intelligent Technology Improvement Relocation and Production Expansion Project for Women's Physiological Health Products Production Line”, terminate the “Digital Health Care and Disinfection and Antibacterial Products Production Line Technical Reform, Relocation and Production Expansion Project”, and permanently supplement working capital with related raised capital.

Renhe Pharmaceutical announced that it plans to adjust the investment scale and complete the “Digital Intelligent Technology Improvement Relocation and Production Expansion Project for Women's Physiological Health Products Production Line”, terminate the “Digital Health Care and Disinfection and Antibacterial Products Production Line Technical Reform, Relocation and Production Expansion Project”, and permanently supplement working capital with related raised capital.